Pizotyline-induced cholestatic jaundice

Area of Science:

• Hepatology
• Clinical Pharmacology

Background:

• Drug-induced liver injury (DILI) is a significant clinical concern.
• Phenothiazine-related compounds are known to have potential hepatotoxic effects.
• Cholestatic jaundice presents diagnostic challenges, mimicking hepatitis or biliary obstruction.

Observation:

• A patient presented with symptoms suggestive of hepatitis or biliary obstruction.
• Initial diagnostic workup aimed to differentiate between these conditions.
• A detailed patient history revealed the ingestion of pizotyline.

Findings:

• Pizotyline, a phenothiazine-related drug, was identified as the causative agent.
• Clinical presentation and histological examination supported the diagnosis of drug-induced cholestasis.
• Laboratory studies were crucial in excluding other causes of jaundice.

Implications:

• This case highlights the importance of considering drug-induced hepatotoxicity in cholestatic jaundice.
• Accurate identification of causative agents like pizotyline is vital for patient management.
• Pharmacovigilance for phenothiazine derivatives is essential to prevent adverse drug events.